DCC1998 |
Erioflorin |
Novel ATP-competitive Selective c-Jun N-terminal kinase (JNK) inhibitor |
|
DCC1999 |
Eritoran |
Analogue of the lipid A portion of the endotoxin lipopolysaccharide (LPS) with potential immunomodulating activity, binding to the Toll-like receptor (TLR)/CD14/MD2 receptor complex, inhibiting the activation of the receptor complex by LPS |
|
DCC2000 |
Erk Inhibitor Ii, Negative Control |
Negative control for ERK Inhibitor II AOB6420 |
|
DCC2001 |
Erk-cliptac |
Novel degrader of ERK1/2, eliciting downregulation of phospho-ERK1/2 signal. |
|
DCC2002 |
Errα Degrader-1 |
Novel PROTAC Estrogen-related Receptor α (ERRα) Degrader |
|
DCC2003 |
Erso-dfp |
Novel Activator of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer |
|
DCC2004 |
Erß Nir Probe P5 |
The first ERβ-targeted near-infrared (NIR) inherently fluorescent probe, showing the advantages of high ERβ selectivity, good optical properties, and excellent ERβ imaging capability in living cells |
|
DCC2005 |
Ertapenem Disodium |
Carbapenem antibiotic, inhibiting cross-linking of the peptidoglycan layer of bacterial cell walls by blocking penicillin-binding proteins (PBPs) |
|
DCC2006 |
Erthermac |
Novel thermosensitive fluorescent dye, visualizing thermogenesis in stimulated single-cell brown adipocytes |
|
DCC2007 |
Er-thermo-yellow |
The First Fluorescent Probe for Targeted Visualization of Temperature at the Endoplasmic Reticulum #222222; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.17px; text-align: start; text-in |
|
DCC2008 |
Erw1041e |
Novel potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the close related enzyme TG1 |
|
DCC2009 |
Erythrocentaurin |
Anti-HBV agent, showing activities on HepG 2.2.15 cell line in vitro |
|
DCC2010 |
Erythro-di-o-benzyl Droxidopa Hcl |
Precursor of adrenaline, suppressing the locomotor stimulation by MAO inhibitor |
|
DCC2011 |
Erythromycin Ethylsuccinate |
Broad-spectrum, topical macrolide antibiotic, diffusing through the bacterial cell membrane and reversibly binding to the 50S subunit of the bacterial ribosome |
|
DCC2012 |
escaline Hydrochloride |
Serotonin 5-HT2A Agonist |
|
DCC2013 |
Est64454 |
Novel Highly Soluble σ1 Receptor Antagonist for Pain Management |
|
DCC2014 |
Estetrol |
Selective estrogen receptor modulator (SERM), exhibiting estrogen agonism in certain tissues and estrogen antagonism in others |
|
DCC2015 |
Cgs-27023a |
Non-Peptidic, potent, and orally active stromelysin inhibitor, blocking cartilage degradation |
|
DCC2016 |
Etb067 |
H-89 analog as PKA and AKT1 inhibitor with specificity on no longer inhibiting CAMK2B and neither affecting viability of mice nor causing any detectable tissuedamage at the dose given |
|
DCC2017 |
Etc-131 |
Novel inhibitor of PORCN, inhibiting ß-catenin reporter activity in a dose-dependent manner |
|
DCC2018 |
Ethd-1 |
Cell-impermeant viability indicator, as high-affinity nucleic acid stain that is weakly fluorescent until bound to DNA and emits red fluorescence (excitation/emission maxima ~528/617). |
|
DCC2019 |
Etheofazine |
Novel anticancer agent |
|
DCC2020 |
Ethyl 3-hydroxyhexanoate |
Natural potent antiviral agent, significantly inhibiting coxsackievirus group B (CVB) replication both in vivo and in vitro |
|
DCC2021 |
Ethyl Lipotf |
Novel selective FTO inhibitor |
|
DCC2022 |
Ethylvanillin |
TRPA1 channel agonist |
|
DCC2023 |
Etifoxine |
Activator of β2 and β3 subunit containing channels of the GABAA receptor complex, stimulating the production of GABA(A) active neurosteroids |
|
DCC2024 |
Et-kuq |
Novel enhancer of the religation reaction of human topoisomerase I |
|
DCC2025 |
et-nhp5g |
Partial agonist at the glutamate binding site of the GluN2 subunits |
|
DCC2026 |
Etoxazole |
Pesticide, acting as antibiotics or growth regulators to kill mites and ticks |
|
DCC2027 |
etp-45299 |
Potent and selective inhibitor of Pim 1, inhibiting the phosphorylation of Bad and 4EBP1 in cells and suppresses the proliferation of several non-solid and solid human tumor cell lines. |
|